Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.89B | $ 2.95B | $ 2.89B | $ 2.83B | $ 2.15B |
| Gross Profit | $ 1.00B | $ 1.13B | $ 1.14B | $ 1.17B | $ 767.90M |
| Operating Income | $ 594.60M | $ 710.90M | $ 763.50M | $ 758.70M | $ 419.00M |
| EBITDA | $ 743.80M | $ 844.10M | $ 808.10M | $ 879.70M | $ 518.90M |
| Net Income | $ 492.70M | $ 593.40M | $ 585.90M | $ 661.80M | $ 346.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 484.60M | $ 853.90M | $ 894.30M | $ 762.60M | $ 615.50M |
| Total Assets | $ 3.64B | $ 3.83B | $ 3.62B | $ 3.31B | $ 2.79B |
| Total Debt | $ 305.30M | $ 309.00M | $ 317.90M | $ 325.30M | $ 325.70M |
| Net Debt | $ -179.30M | $ -544.90M | $ -576.40M | $ -437.30M | $ -289.80M |
| Total Liabilities | $ 961.10M | $ 948.50M | $ 931.90M | $ 978.40M | $ 939.30M |
| Stockholders' Equity | $ 2.68B | $ 2.88B | $ 2.68B | $ 2.34B | $ 1.85B |
| Cash Flow | |||||
| Free Cash Flow | $ 276.40M | $ 414.50M | $ 439.40M | $ 330.60M | $ 298.10M |
| Operating Cash Flow | $ 653.40M | $ 776.50M | $ 724.00M | $ 584.00M | $ 472.50M |
| Investing Cash Flow | $ -378.70M | $ -368.70M | $ -288.20M | $ -253.10M | $ -179.50M |
| Financing Cash Flow | $ -622.60M | $ -459.60M | $ -293.60M | $ -168.10M | $ -137.10M |